The pharmacological management of the behavioral aspects of Parkinson's disease: an update.
Marta CampagnoloAron EmmiRoberta BiundoEleonora FiorenzatoLucia BatzuK Ray ChaudhuriAngelo AntoniniPublished in: Expert opinion on pharmacotherapy (2023)
We conducted a narrative review searching for articles on behavioral symptoms in Parkinson disease and selected those which included involved neurotransmitters such as dopamine, noradrenaline, serotonin, acetylcholine. We specifically focused our search on open-label and randomized double-blind studies and biomarkers which could best characterize these clinical manifestations.